Abstract
Monitoring of total parenteral nutrition (TPN) by drug use evaluation appears to be a reasonable approach to characterizing use of parenteral nutrition within an institution. Development of specific criteria for use of TPN may be difficult because of the broad nature of published guidelines. Criteria for use of TPN in tumor-bearing patients is controversial. Results from recent investigations conflict with previous generally accepted guidelines for providing TPN in cancer patients. This article reviews published guidelines for use of TPN as well as application of these guidelines for drug use evaluation. Criteria for use of TPN and results of a subsequent drug use evaluation in a cancer institution are presented.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
